Symbotic Buys Cellumation to Boost Sortation Tech
SYM is trading near its 52-week low of $37.68 (7.9% above the low).
Summary
Symbotic is acquiring Cellumation, a move that advances its next-generation sortation technology for the global supply chain. The deal adds a new capability to Symbotic's warehouse automation portfolio, which already carries a $22.7 billion backlog. No financial terms were disclosed, but the strategic fit is clear: sortation is a core piece of high-throughput fulfillment. This follows a strong Q2 with 23% revenue growth and net income.
At the time of this announcement, SYM was trading at $40.65 on NASDAQ in the Technology sector, with a market capitalization of approximately $24.7B. The 52-week trading range was $37.68 to $87.88. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.